Brain, Vol. 126, No. 2, 312-325,
February 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg035
Dopamine release during sequential finger movements in health and Parkinson’s disease: a PET study
1 MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, 2 MRC Cognition and Brain Sciences Unit, Cambridge, UK, 3 INB-CNR, 4 University of Milano Bicocca and 5 S. Raffaele Institute Milano, Italy. Corresponding author: Andrew Lawrence, MRC Cognition and Brain Sciences Unit, 15 Chaucer Road, Cambridge CB2 2EF, UK E-mail: andrew.lawrence{at}mrc-cbu.cam.ac.uk
Parkinson’s disease is associated with slowness, especially of sequential movements, and is characterized pathologically by degeneration of dopaminergic neurons, particularly targeting nigrostriatal projections. In turn, nigrostriatal dopamine has been suggested to be critical for the execution of sequential movements. The objective of this study was to investigate in vivo, with [11C]raclopride, PET changes in regional brain levels of dopamine in healthy volunteers and Parkinson’s disease patients during the execution of paced, stereotyped sequential finger movements. Striatal [11C]raclopride binding reflects dopamine D2 receptor availability and is influenced by synaptic levels of endogenous dopamine. During execution of a pre-learned sequence of finger movements, a significant reduction in binding potential (BP) of [11C]raclopride was seen in both caudate and putamen in healthy volunteers compared with a resting baseline, consistent with release of endogenous dopamine. Parkinson’s disease patients also showed attenuated [11C]raclopride BP reductions during the same motor paradigm in striatal areas less affected by the disease process. These findings confirm that striatal dopamine release is a component of movement sequencing and show that dopamine release can be detected in early Parkinson’s disease during a behavioural manipulation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Sawamoto, P. Piccini, G. Hotton, N. Pavese, K. Thielemans, and D. J. Brooks Cognitive deficits and striato-frontal dopamine release in Parkinson's disease Brain, May 1, 2008; 131(5): 1294 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Desmurget and R. S. Turner Testing Basal Ganglia Motor Functions Through Reversible Inactivations in the Posterior Internal Globus Pallidus J Neurophysiol, March 1, 2008; 99(3): 1057 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Garraux, P. Peigneux, R. E. Carson, and M. Hallett Task-Related Interaction between Basal Ganglia and Cortical Dopamine Release J. Neurosci., December 26, 2007; 27(52): 14434 - 14441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Androulidakis, A. A. Kuhn, C. Chu Chen, P. Blomstedt, F. Kempf, A. Kupsch, G.-H. Schneider, L. Doyle, P. Dowsey-Limousin, M. I. Hariz, et al. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease Brain, February 1, 2007; 130(2): 457 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al. Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens. Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pavese, A. Gerhard, Y. F. Tai, A. K. Ho, F. Turkheimer, R. A. Barker, D. J. Brooks, and P. Piccini Microglial activation correlates with severity in Huntington disease: A clinical and PET study Neurology, June 13, 2006; 66(11): 1638 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Brody, R. E. Olmstead, E. D. London, J. Farahi, J. H. Meyer, P. Grossman, G. S. Lee, J. Huang, E. L. Hahn, and M. A. Mandelkern Smoking-Induced Ventral Striatum Dopamine Release Am J Psychiatry, July 1, 2004; 161(7): 1211 - 1218. [Abstract] [Full Text] [PDF]
|
|